47. ASSESSMENT OF THE FLUCTUATION OF ANTI SARS-COV-2 IGG CONCENTRATION IN VACCINATED PEOPLE, APPLICATION IN COVID-19 PREVENTION
Main Article Content
Abstract
Objectives: Describe the clinical characteristics of vaccinated people and study the changes in anti-SARS-CoV-2 IgG levels in people vaccinated with the COVID-19 vaccine.
Research subjects and methods: Cross-sectional descriptive study divided into 3 time points: T6 (6 months after vaccination: 400 people); T12 (12 months after vaccination: 404 people); T18 (18 months after vaccination: 411 people) on people after vaccination with CoVid-19, the medical staff of hospitals in Hanoi and volunteers participating in the study.
Results: Regarding vaccine type: the 1st and 2nd doses of all 3 groups were mainly injected with Astrazeneca vaccine, and the 3rd and 4th doses of groups T6, T12, and T18 were mainly injected with Pfize vaccine. Regarding blood type, all 3 groups had the highest rate of blood type O+ at 43.8%, 46%, and 41.6%, respectively. Regarding the number of vaccinations, groups T6 and T12 have the highest rate of 4 vaccinations at 66.3% and 82.17%, respectively; group T18 has the highest rate of 3 vaccinations at 58.6%. Antibody concentration: group T6 has the highest antibody concentration with a median of 299.78 IU/ml, group T12 has a lower antibody concentration with a median of 162.33 IU/ml, and group T18 has the lowest antibody concentration with a median of 98.19 IU/ml.
Conclusion: Group T6 BMI: underweight and obese groups had significantly lower antibody concentrations; Antibody concentrations decreased over time, highest in the 6-month postvaccination group and lowest in the 18-month post-vaccination group.
Article Details
Keywords
Covid 19, anti-SAR CoV-2 IgG, vaccines, Son Tay General Hospital
References
[2] A. P. S. Munro, C. E. Jones và S. N. Faust (2024). Vaccination against COVID-19 - risks and benefits in children. Eur J Pediatr, 183 (3), 1107-1112.
[3] M. Chivu-Economescu, T. Vremera, S. M. Ruta và cộng sự (2022). Assessment of the Humoral Immune Response Following COVID-19 Vaccination in Healthcare Workers: A One Year Longitudinal Study. Biomedicines, 10 (7),
[4] O. S. Almalki, E. Y. Santali, A. A. Alhothali và cộng sự (2023). The role of blood groups, vaccine type and gender in predicting the severity of side effects among university students receiving COVID-19 vaccines. BMC Infect Dis, 23 (1), 378.
[5] E. Nicolai, F. Tomassetti, M. Pelagalli và cộng sự (2023). The Antibodies' Response to SARSCoV-2 Vaccination: 1-Year Follow Up. Biomedicines, 11 (10),
[6] C. Dimeglio, P. Trémeaux, F. Herin và cộng sự (2022). Post-vaccination SARS-CoV-2 antibody kinetics and protection duration against Omicron in elderly population. J Infect, 85 (6), 702-769.
[7] L. L. van den Hoogen, M. Boer, A. Postema và cộng sự (2022). Reduced Antibody Acquisition with Increasing Age following Vaccination with BNT162b2: Results from Two Longitudinal Cohort Studies in The Netherlands. Vaccines (Basel), 10 (9),
[8] K. Kontopoulou, C. T. Nakas, C. Belai và cộng sự (2022). Antibody titers after a third dose of the SARS-CoV-2 BNT162b2 vaccine in immunocompromised adults in Greece: Is a fourth dose necessary? J Med Virol, 94 (10), 5056-5060.
[9] S. Y. Nam, S. W. Jeon, D. K. Jung và cộng sự (2022). Body Weight is Inversely Associated with Anti-SARS-CoV-2 Antibody Levels after BNT162b2 mRNA Vaccination in Young and Middle Aged Adults. Infect Chemother, 54 (3), 504-516.